Medpace Holdings, Inc. (MEDP)
620.10
-0.66
(-0.11%)
USD |
NASDAQ |
Aug 24, 16:00
620.10
0.00 (0.00%)
After-Hours: 20:00
Medpace Holdings Shareholders Equity (Quarterly) : 433.86M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 433.86M |
| March 31, 2026 | 598.31M |
| December 31, 2025 | 459.07M |
| September 30, 2025 | 293.64M |
| June 30, 2025 | 172.35M |
| March 31, 2025 | 593.61M |
| December 31, 2024 | 825.54M |
| September 30, 2024 | 881.44M |
| June 30, 2024 | 763.60M |
| March 31, 2024 | 671.54M |
| December 31, 2023 | 558.95M |
| September 30, 2023 | 470.91M |
| June 30, 2023 | 391.06M |
| March 31, 2023 | 347.26M |
| December 31, 2022 | 386.39M |
| September 30, 2022 | 349.88M |
| June 30, 2022 | 283.25M |
| March 31, 2022 | 605.02M |
| December 31, 2021 | 952.93M |
| September 30, 2021 | 898.08M |
| June 30, 2021 | 851.88M |
| March 31, 2021 | 858.93M |
| December 31, 2020 | 805.78M |
| Date | Value |
|---|---|
| September 30, 2020 | 791.63M |
| June 30, 2020 | 738.07M |
| March 31, 2020 | 717.80M |
| December 31, 2019 | 726.28M |
| September 30, 2019 | 692.01M |
| June 30, 2019 | 658.06M |
| March 31, 2019 | 621.90M |
| December 31, 2018 | 589.70M |
| September 30, 2018 | 561.39M |
| June 30, 2018 | 540.08M |
| March 31, 2018 | 511.07M |
| December 31, 2017 | 503.53M |
| September 30, 2017 | 550.25M |
| June 30, 2017 | 607.36M |
| March 31, 2017 | 620.98M |
| December 31, 2016 | 610.71M |
| September 30, 2016 | 610.54M |
| June 30, 2016 | 422.64M |
| March 31, 2016 | 417.86M |
| December 31, 2015 | 413.47M |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 0.00 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 6.171B |
| Charles River Laboratories International, Inc. | 2.840B |
| Avantor, Inc. | 5.630B |
| Champions Oncology, Inc. | 3.939M |
| Personalis, Inc. | 235.16M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.057B |
| Total Liabilities (Quarterly) | 1.623B |
| Debt to Equity Ratio | 0.3322 |
| Current Ratio | 0.7317 |
| Net Debt Paydown Yield | 0.01% |